(19)
(11) EP 1 771 174 A1

(12)

(43) Date of publication:
11.04.2007 Bulletin 2007/15

(21) Application number: 05742454.1

(22) Date of filing: 17.05.2005
(51) International Patent Classification (IPC): 
A61K 31/4745(2006.01)
A61P 35/00(2006.01)
A61K 31/4745(2006.01)
A61K 31/7068(2006.01)
A61K 31/7068(2006.01)
(86) International application number:
PCT/IB2005/001467
(87) International publication number:
WO 2005/115391 (08.12.2005 Gazette 2005/49)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 28.05.2004 US 575145 P

(71) Applicant: Pfizer Products Inc.
Groton, Connecticut 06340 (US)

(72) Inventors:
  • MILLER, Langdon LeForrest
    Lebanon, NJ 08833 (US)
  • DENIS, Louis Jean
    New London, CT 06320 (US)
  • COMPTON, Linda Darlene
    Kalamazoo, MI 49001 (US)

(74) Representative: Dekker, Henrike Cornelie Christine 
Pfizer European Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) METHOD FOR TREATING ABNORMAL CELL GROWTH